ES2189173T3 - Derivados de 20-aril-5alfa-pregnano. - Google Patents

Derivados de 20-aril-5alfa-pregnano.

Info

Publication number
ES2189173T3
ES2189173T3 ES98924316T ES98924316T ES2189173T3 ES 2189173 T3 ES2189173 T3 ES 2189173T3 ES 98924316 T ES98924316 T ES 98924316T ES 98924316 T ES98924316 T ES 98924316T ES 2189173 T3 ES2189173 T3 ES 2189173T3
Authority
ES
Spain
Prior art keywords
sub
delta
alkyl
alkoxide
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98924316T
Other languages
English (en)
Inventor
Johannes Antonius Joseph Leemhuis
Der Louw Jaap Van
Marinus Bernard Groen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2189173T3 publication Critical patent/ES2189173T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Las invención se refiere a un derivado del 20-aralquil-5a-pregnan que tiene la fórmula general (I), o a una sal farmacológicamente aceptable del mismo, en donde R{sub, 1} es (H, OR), (H, OSO{sub, 3}H) o NOR; R es H, alquilo C{sub,1-6} o acilo C{sub,1-6}; cada R{sub, 2} y R{sub, 3} es independientemente hidrógeno o alquilo C{sub,1-6}; X es un radical hidrocarburo divalente de cadena recta C{sub,1-8}, que comprende opcionalmente un enlace doble o triple; o X es -(CH{sub,2}){sub,m}-CR{sub,7}R{sub,8}-; m = 0-4; al menos una de R{sub,7} y R{sub,8} es alquilo C{sub,1-4} hidróxido, alcóxido C{sub,1-4} o halógeno; el otro, si estuviera presente, es hidrógeno; o R{sub,7} y R{sub,8} representan juntos O o NOR''; R'' es H, alquilo C{sub,1-6} o acilo C{sub,1-6}; cada R{sub,4}, R{sub,5} y R{sub,6} son independientemente hidrógeno, hidróxido, alcóxido C{sub,1-4}, halógeno, NR{sub,9}R{sub,10} o alquilo C{sub,1-4}, opcionalmente sustituido por hidróxido, alcóxido, halógeno u oxo; cada R{sub,9} y R{sub,10} es independientemente hidrógeno o alquilo C{sub,1-4} y las líneas punteadas indican un enlace doble "DELTA" 7 o "DELTA" 8 o bien un par de enlaces dobles conjugados seleccionados entre "DELTA" 7,14, "DELTA" 8,14, "DELTA" 6,8(14). Los compuestos de la invención tienen actividad activadora de la meiosis y pueden utilizarse para el control de la fertilidad.
ES98924316T 1997-05-16 1998-05-11 Derivados de 20-aril-5alfa-pregnano. Expired - Lifetime ES2189173T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201474 1997-05-16

Publications (1)

Publication Number Publication Date
ES2189173T3 true ES2189173T3 (es) 2003-07-01

Family

ID=8228325

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98924316T Expired - Lifetime ES2189173T3 (es) 1997-05-16 1998-05-11 Derivados de 20-aril-5alfa-pregnano.

Country Status (17)

Country Link
US (1) US6177420B1 (es)
EP (1) EP0984980B1 (es)
JP (1) JP2001526673A (es)
KR (1) KR20010012643A (es)
CN (1) CN1260802A (es)
AT (1) ATE229032T1 (es)
AU (1) AU726016B2 (es)
BR (1) BR9808803A (es)
CA (1) CA2289675A1 (es)
DE (1) DE69809905T2 (es)
DK (1) DK0984980T3 (es)
ES (1) ES2189173T3 (es)
HU (1) HUP0002331A3 (es)
NO (1) NO995590L (es)
PL (1) PL337008A1 (es)
TR (1) TR199902793T2 (es)
WO (1) WO1998052965A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2181321T3 (es) * 1997-12-18 2003-02-16 Akzo Nobel Nv Derivados 17beta-aril(arilmetil)oxi(tio)alquilandrostano.
DE69913513T2 (de) * 1998-05-13 2004-09-30 Novo Nordisk A/S Verwendung von verbindungen mit der fähigkeit die meiose zu regulieren
AU4498299A (en) * 1998-06-19 2000-01-10 Novo Nordisk A/S Meiosis regulating compounds
JP2002538123A (ja) * 1999-03-02 2002-11-12 アクゾ・ノベル・エヌ・ベー （アンドロスト−５−エン−１７β−イル）アルキルスルホキシドおよびスルホンならびに受胎能の調節のためのその使用
US6756366B1 (en) * 1999-04-06 2004-06-29 Akzo Nobel N.V. Orally active androgens
EP1127890A1 (en) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
US6988613B2 (en) * 2001-02-06 2006-01-24 Novo Nordisk A/S Composition for IVF
WO2005020928A2 (en) 2003-08-29 2005-03-10 The Regents Of The University Of California Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
CN1906207A (zh) 2004-01-15 2007-01-31 沃纳奇尔科特公司 乙炔雌二醇的二－甾族前体药物
US7067505B2 (en) 2004-01-15 2006-06-27 Warner Chilcott Company, Inc. Di-steroidal prodrugs of estradiol
CN101218245B (zh) 2005-07-12 2011-08-17 沃纳奇尔科特有限责任公司 炔雌醇的3-酯前药
US9670244B2 (en) 2006-02-27 2017-06-06 The Regents Of The University Of California Oxysterol compounds and the hedgehog pathway
CN101951915A (zh) 2007-12-03 2011-01-19 加利福尼亚大学董事会 用于刺猬蛋白信号、骨诱导、抗脂肪形成和wnt信号的激活的氧固醇
WO2013169399A1 (en) 2012-05-07 2013-11-14 The Regents Of The University Of California Oxysterol analogue oxy133 induces osteogenesis and hedgehog signaling and inhibits adipogenesis
US9683009B2 (en) 2013-05-02 2017-06-20 The Regents Of The University Of California Bone-selective osteogenic oxysterol-bone targeting agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
PL322106A1 (en) 1995-03-06 1998-01-05 Novo Nordisk As Meiosis stimulation
PL185622B1 (pl) * 1995-06-23 2003-06-30 Novo Nordisk As Zastosowanie związku steroidowego i sposób regulacji mejozy w komórce rozrodczej ssaka

Also Published As

Publication number Publication date
EP0984980B1 (en) 2002-12-04
WO1998052965A1 (en) 1998-11-26
AU726016B2 (en) 2000-10-26
JP2001526673A (ja) 2001-12-18
US6177420B1 (en) 2001-01-23
PL337008A1 (en) 2000-07-31
AU7654998A (en) 1998-12-11
ATE229032T1 (de) 2002-12-15
NO995590D0 (no) 1999-11-15
CA2289675A1 (en) 1998-11-26
NO995590L (no) 2000-01-11
CN1260802A (zh) 2000-07-19
KR20010012643A (ko) 2001-02-26
EP0984980A1 (en) 2000-03-15
HUP0002331A3 (en) 2001-05-28
DE69809905D1 (de) 2003-01-16
DE69809905T2 (de) 2003-08-28
HUP0002331A2 (hu) 2000-12-28
DK0984980T3 (da) 2003-03-17
BR9808803A (pt) 2000-07-18
TR199902793T2 (xx) 2000-06-21

Similar Documents

Publication Publication Date Title
ES2106616T3 (es) Derivados de 11,21-bisfenilo-19-nor-pregnanos.
NO2018005I1 (no) tivozanib eller et salt eller solvat derav
ES2126499B1 (es) Coiniciadores de borato para fotopolimerizacion.
ES2195034T3 (es) Inhibidor de metaloproteinasas, composicion farmaceutica que contiene este inhibidor y su utilizacion farmaceutica, y procedimientos que sirven para su preparacion.
UY26754A1 (es) Derivados de la 1, 3, 8, -triaza-spiro (4,5) decan-4-ona
ES2123287T3 (es) Derivados 3-benzoil benzofuranicos como antagonistas de la hormona tiroidea.
PE20010613A1 (es) Antagonistas de la hormona concentradora de la melanina
ES2112650T3 (es) Sales de un derivado de indol antimigraña.
ES2171577T3 (es) Kappa-opiaceos para enfermedades intestinales inflamatorias.
AR023497A1 (es) Ent-esteroides en calidad de estrogenos con efecto selectivo, su empleo para el tratamiento de las enfermedades y los estados motivados por una deficienciade estrogenos en la mujer y en el hombre, y las composiciones farmaceuticas que contienen estos ent-esteroides
CO5011076A1 (es) Derivados de prolina - d
BR0112093A (pt) Derivados de sulfonil-pirrolidina úteis no tratamento de distúrbios neurológicos
ATE229032T1 (de) 20-aralkyl-5,alpha,-pregnan derivate
ES2156287T3 (es) Derivados de difenilmetilen piperidina.
NO306020B1 (no) N-alkylthiopolyaminderivater som radiobeskyttende midler
MX9201805A (es) Derivados de n-imidazolilo de indol substituido, procedimiento para su preparacion y composicion farmaceutica que los contiene.
UY26920A1 (es) 7 - oxo piridopirimidinas
AR007997A1 (es) Un derivado de distamicina sustituida con acriloilo, sus utilizaciones, un procedimiento para producirlo y una composicion farmaceutica que lo comprende.
DK0686143T3 (da) Umættede aminoforbindelser som middel mod cancer og mod protozoer
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
ES2070002T3 (es) Composiciones terapeuticas a base de derivados de 1,2-ditiol-3-tiona.
DK0399519T3 (da) Potensering af celleformidlet immunitet under anvendelse af polyaminderivater
ATE215555T1 (de) 17-beta.-allyloxy(thio)alkyl-androstan derivative zur modulation von meiose
SE0002211D0 (sv) Methods and compositions for prevention of myopia
UY25708A1 (es) Dihidropironas inhibidoras de hiv proteasa